The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization

dc.contributor.author	Pipa Muñiz, M.
dc.contributor.author	Sanmartino, Susana
dc.contributor.author	Mesa Álvarez, Alicia
dc.contributor.author	Álvarez Navascués, Carmen
dc.contributor.author	González Diéguez, María Luisa
dc.contributor.author	Cadahía Rodrigo, Valle
dc.contributor.author	Rodríguez, J. E.
dc.contributor.author	Vega, F.
dc.contributor.author	Rodríguez, M.
dc.contributor.author	Costilla García, Serafín Marcos
dc.contributor.author	Varela Calvo, María
dc.date.accessioned	2020-09-24T07:44:20Z
dc.date.available	2020-09-24T07:44:20Z
dc.date.issued	2020
dc.identifier.citation	BMC Gastroenterology, 20(1), p. 166- (2020); doi:10.1186/s12876-020-01307-x
dc.identifier.issn	1471-230X
dc.identifier.uri	http://hdl.handle.net/10651/56745
dc.format.extent	p. 166-
dc.language.iso	eng
dc.relation.ispartof	BMC Gastroenterology
dc.rights	© 2020 Pipa Muñiz et al.
dc.rights	CC Reconocimiento 4.0 Internacional
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085910024&doi=10.1186%2fs12876-020-01307-x&partnerID=40&md5=e04dc23a35f938d20b5a27663c3fd3bc
dc.title	The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization
dc.type	journal article
dc.identifier.doi	10.1186/s12876-020-01307-x
dc.relation.publisherversion	http://dx.doi.org/10.1186/s12876-020-01307-x
dc.rights.accessRights	open access
dc.type.hasVersion	VoR

Este ítem está sujeto a una licencia Creative Commons